New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Editor's Top Picks
AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study
A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in…
Submit Your Paper →
More form New Studies
Caffeine Boosts Lifting Performance Through Neural Enhancement, New Trial Shows
New research shows caffeine improves lifting performance by 5-12% through neural enhancement rather than muscle…
New Research Reveals Why Explosive Athletic Performance Isn’t Just About Speed or Strength
New biomechanical research reveals explosive athletic performance isn't about speed or strength alone, but depends…
Daily Multivitamins May Slow Biological Aging and Cognitive Decline, Major Study Finds
New research shows daily multivitamins can slow biological aging and delay cognitive decline by 2…
Creatine’s Brain Benefits Under Scientific Scrutiny: Evidence Gap Between Marketing and Research
Comprehensive review of 35 studies reveals significant evidence gaps between creatine's proven muscle benefits and…
Essential Minerals Drive All Body Functions, New Research Shows
New research shows essential minerals function as an interconnected network, with deficiencies in one mineral…